Compare COTY & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COTY | LMAT |
|---|---|---|
| Founded | 1904 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.1B |
| IPO Year | 2012 | 2006 |
| Metric | COTY | LMAT |
|---|---|---|
| Price | $2.83 | $81.17 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 16 | 5 |
| Target Price | $4.18 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 8.0M | 406.4K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 1.42 |
| Revenue | ★ $5,806,600,000.00 | $249,602,000.00 |
| Revenue This Year | $0.10 | $14.21 |
| Revenue Next Year | $1.29 | $8.88 |
| P/E Ratio | ★ N/A | $56.54 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $1.82 | $78.27 |
| 52 Week High | $4.56 | $118.01 |
| Indicator | COTY | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 53.85 | 37.55 |
| Support Level | $2.48 | $79.02 |
| Resistance Level | $3.02 | $88.35 |
| Average True Range (ATR) | 0.16 | 1.93 |
| MACD | -0.01 | 0.37 |
| Stochastic Oscillator | 51.90 | 38.65 |
Coty is a global beauty maker that generates 65% of sales from prestige beauty products (primarily fragrances) and 35% from mass makeup, skin care, and fragrance. For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein. In contrast, its consumer cosmetics business focuses on acquired mass brands such as CoverGirl, Max Factor, Rimmel, Sally Hansen, and Bourjois. It also collaborates with social media celebrity Kylie Jenner to manage makeup products bearing her name. By region, Coty generates close to 48% of sales from Europe, 40% from the Americas, and 12% from Asia-Pacific. German investment firm JAB is a controlling shareholder, with a 54% stake.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.